Appetite-suppressing drugs like Ozempic and Mounjaro could prevent up to 6.6 million deaths annually and free up 32 million hectares of agricultural land by 2050 through reduced global calorie demand, according to a computer simulation published November 19 in Nature Communications.
About 100 million people already use GLP-1 medications worldwide. Researchers from the University of Aberdeen, the University of Edinburgh, and Scotland’s Rural College modeled how widespread uptake among adults living with obesity might alter international trade, food prices, and farming.
“Our findings suggest that these changes in food consumption could have consequences that extend beyond the individuals receiving treatment, including potentially reducing pressure on natural land in other parts of the world,” Dr. Roslyn Henry from the University of Aberdeen said.
| Scenario Type | Avoided Deaths (Annual) | Land Freed from Agriculture |
|---|---|---|
| GLP-1 Use Alone | 6.6 million | 32 million hectares (79 million acres) |
| GLP-1 Combined with Healthy Diets | 7.7 million | 46 million hectares (114 million acres) |
Lower food demand may reduce prices
Lower food demand from medication users could drive down food prices globally. While cheaper food sounds positive, researchers said that lower prices might encourage greater consumption among non-users.
That rebound could offset some of the intended health benefits, particularly if increased purchases lean toward meat and sugar. “Lower prices and shifting demand may drive increased consumption of meat and sugar,” the researchers wrote.
“What we eat has consequences that extend beyond our own health,” said Professor Peter Alexander of the University of Edinburgh, a co-author of the study. “Our food choices ripple through global food systems, affecting what farmers produce, what countries trade and how much land is needed for agriculture.”
Authors warn against blaming individuals
The study’s authors cautioned against framing the findings as an environmental solution or placing climate responsibility on people living with obesity. Henry emphasized that individual willpower does not dictate diets alone.
“However, it’s important that these findings aren’t interpreted as placing environmental responsibility on people living with obesity, or suggesting that medication is an environmental solution,” Henry said. “The environmental impacts of what we eat are shaped by the wider food system, not simply by individual choices.”
A UK government-commissioned national food strategy finalized in 2021 reached a similar conclusion regarding the wider food environment. That report argued that improving public diets requires making healthy options affordable and accessible rather than simply asking individuals to choose better.

Frequently Asked Questions About GLP-1 Food System Modeling
Did the study predict that everyone will take GLP-1 drugs by 2050?
No. Researchers emphasized that the study serves as an initial exploratory assessment rather than a forecast of future treatment trajectories or a recommendation for universal treatment.
Does freeing up agricultural land automatically restore wildlife habitats?
The simulation did not assess habitat quality or calculate greenhouse gas emissions, including manufacturing emissions associated with the medications.
How were the healthier diet scenarios defined in the simulation?
The healthier eating pattern paired with GLP-1 use was an added assumption in the model based on shifts toward the EAT–Lancet diet, rather than an established physiological consequence of taking the medications.
Founded in 1495 as King’s College by papal bull from Pope Alexander VI, the University of Aberdeen is the fifth-oldest university in the English-speaking world and one of Scotland’s four ancient universities.
It assumed its current form in 1860 through a merger with Marischal College, a Protestant alternative founded in 1593. The institution established the first chair of medicine in the English-speaking world in 1497 and its Foresterhill campus now forms one of Europe’s largest health campuses alongside Aberdeen Royal Infirmary.
What factors could change these 2050 projections?
Alternative future assumptions regarding patient adherence, treatment duration, medication costs, treatment discontinuation, and weight regain could substantially alter the modeled outcomes.
Keep reading